Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Canadian group synthesizes novel PCSK9 inhibitors for LDL-C

Oct. 7, 2014

DecImmune Therapeutics awarded SBIR grant to support DeciMab studies

Oct. 7, 2014

Bristol-Myers Squibb reports new KCNA5 channel blockers for arrhythmia

Oct. 6, 2014

BI-415756, a novel potent CETP inhibitor for the treatment of cardiovascular diseases

Oct. 3, 2014

Allosteros Therapeutics divulges novel CaMK-II inhibitors

Oct. 1, 2014

Novel ROCK1 and ROCK2 inhibitors disclosed by Bristol-Myers Squibb

Sep. 23, 2014

Sanofi and MyoKardia form collaboration to develop treatments for genetic cardiomyopathies

Sep. 22, 2014

Treprost injection solution launched in Japan

Sep. 19, 2014

Alnylam Pharmaceuticals describes siRNA for treating pre-eclampsia

Sep. 18, 2014

CellProThera and BioCardia agree to partner on phase II EXCELLENT trial

Sep. 17, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...